Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations.
Mishell
Daniel R
DR
Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. mishell@usc.edu
D002626:Chemistry, Pharmaceutical; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D008597:Menstrual Cycle
D003277:Contraceptives, Oral, Combined